Ali et al. examined SCUBE2 expression in T2DM patients with dyslipidemia and found that upregulation of SCUBE2 expression in dyslipidemic T2DM is associated with higher levels of ET-1 when compared with controls [13]. This evidence concerns the gene SCUBE2 and metabolic syndrome.